Fortification of enriched cereal grain flour products with folic acid has drastically reduced the prevalence of deficient plasma folate status, a major determinant of plasma total homocysteine (tHcy) levels. We hypothesized that even more liberally defined "suboptimal" plasma folate status might no longer contribute importantly to the population attributable risk (PAR) for mild hyperhomocysteinemia, a putative atherothrombotic risk factor. We determined fasting plasma tHcy, folate, vitamin B 12 , and pyridoxal 5Ј-phosphate levels, along with serum creatinine and albumin levels, in 267 consecutive patients (aged 61Ϯ9 [meanϮSD] years, 76.4% men and 26.6% women) with stable coronary artery disease (CAD) who were nonusers of vitamin supplements or had abstained from supplement use for at least 6 weeks before examination. Subjects were evaluated a minimum of 3 months after the implementation of flour fortification was largely completed. Relative risk estimates for the calculation of PAR were derived from a multivariable-adjusted logistic regression model with Ն12 mol/L tHcy as the dependent variable and with age, sex, pyridoxal 5Ј-phosphate (continuous), albumin (continuous), Ͻ5 ng/mL folate, Ͻ250 pg/mL vitamin B 12 , and Ն1.3 mg/dL creatinine as the independent variables. The prevalence of Ն12 mol/L plasma tHcy was 11.2% (30 of 267 patients). PAR estimates (percentage) for Ն12 mol/L tHcy were as follows: Ͻ5 ng/mL folate (Ͻ1%), Ͻ250 pg/mL vitamin B 12 (24.5%), and Ն1.3 mg/dL creatinine (37.5%). In the era of folic acid-fortified cereal grain flour, renal insufficiency and suboptimal vitamin B 12 status (but not folate status) contribute importantly to the PAR for mild hyperhomocysteinemia among patients with stable CAD. (Arterioscler Thromb Vasc Biol. 2001;21:849-851.) 
U eland et al 1 recently reported a meta-analysis of 14
prospective studies of the relationship between baseline total homocysteine (tHcy) levels and (primarily) coronary artery disease (CAD) outcomes in population-based cohorts; this meta-analysis was reported through the end of 1999. The aggregate relative risk estimate (from a total of 2786 cases) per 5 mol/L change in tHcy concentration was 1.20 (95% CI 1.14 to 1.25). Nephrosclerosis, specifically renal arteriolar hyalinization, [2] [3] [4] has been associated with systemic arteriosclerosis 2 and clinical 3 as well as subclinical CAD. 4 There is a strong independent (inverse) association between glomerular filtration rate directly determined by either iohexol clearance 5, 6 or 51 Cr-EDTA clearance 7 and fasting tHcy levels, which encompasses glomerular filtration rates throughout the normative range. A surrogate for glomerular filtration rate 8 and homocysteine generation, 9 creatinine is a significant determinant of tHcy levels in CAD patients 10, 11 and general populations. 12 In a population-based sample with predominantly normal renal function, fortification of enriched cereal grain flour products with folic acid drastically reduced the prevalence of deficient plasma folate status and mild hyperhomocysteinemia. 13 These data contrast starkly with the very limited impact that this fortification policy has had on the prevalence of mild hyperhomocysteinemia among chronic renal transplant recipients, 14 who serve as a valid model for the hyperhomocysteinemia of chronic renal insufficiency, in general. 15 Moreover, renal function gauged as a simple creatinine determination is the major independent determinant of tHcy levels in each of these 2 patient groups with mild to moderate chronic renal insufficiency. 14, 15 In light of such collective findings, [13] [14] [15] we hypothesized that even more liberally defined "suboptimal" plasma folate status might no longer contribute importantly to the population attributable risk (PAR) for mild hyperhomocysteinemia among stable CAD patients. Accordingly, we assessed fasting plasma tHcy and serum creatinine in conjunction with the other established determinants of tHcy levels (ie, age, 16 sex, 16 B-vitamin status, 16 and albumin 17 ) among 267 consecutive patients with clinically stable CAD, all of whom were examined at least 3 to 4 months after fortification of enriched cereal grain flour with folic acid was largely completed. 13 
Methods
The institutional review board at Memorial Hospital of Rhode Island (Pawtucket) approved the study protocol, and all participants provided written informed consent. Study participants were 267 stable CAD patients (ie, they were studied at least 3 months after myocardial infarction or coronary angioplasty and/or at least 6 months after coronary artery bypass graft surgery). CAD status was confirmed by established 12-lead ECG and cardiac isoenzyme (ie, creatine phosphokinase-MB) criteria for definite myocardial infarction and/or unstable angina with angiographically proven Ն50% stenosis of at least 1 major epicardial coronary artery. Participants lived in the Pawtucket and Providence, RI, metropolitan areas, and were examined between October 1997 and May 1999. Information regarding prior vitamin supplement use was obtained by standardized interview, and subjects were either nonusers of any supplements containing folic acid or had abstained from using such supplements for at least 6 weeks by the time of their examination. However, all participants were examined at least 3 to 4 months after the widespread availability in New England (John Watson, Watson Foods, New Haven, Conn, personal communication, 1998) of cereal grain flour products fortified with folic acid at 140 g per 100 g flour. 18 Overnight (10-to 14-hour) fasting blood samples were collected from each participant. Plasma tHcy levels were determined by high-performance liquid chromatography with fluorescence detection, and plasma pyridoxal 5Ј-phosphate (PLP) levels were measured by radioenzymatic (tyrosine decarboxylase) assay, as reported earlier. 16 Plasma folate and vitamin B 12 levels were measured by radioassay (Bio-Rad Quantaphase II). Serum creatinine levels (by Jaffe's test) and albumin levels (by bromcresol method) were determined by using standard techniques adapted for automated clinical chemistry laboratory analyzers.
Descriptive data included arithmetic means with standard deviations and complete ranges or geometric means with interquartile and complete ranges for continuous variables and prevalences (percentages) for discrete variables. The odds ratios (an estimate of relative risk) for the calculation of PAR percentage (PAR%) 19 were derived from a multivariable-adjusted logistic regression model with Ն12 mol/L tHcy as the dependent variable and age, sex, PLP (continuous), albumin (continuous), Ͻ5 ng/mL folate, Ͻ250 pg/mL vitamin B 12 , and Ն1.3 mg/dL creatinine as the independent variables. The dichotomous cut points chosen for mild hyperhomocysteinemia and mild renal insufficiency were consistent with earlier operational definitions. 7, 20, 21 The dichotomous cut points chosen for suboptimal folate and vitamin B 12 status were deliberately selected to be slightly above the most common clinically defined cut points for folate deficiency and vitamin B 12 deficiency of Ͻ3 ng/mL and Ͻ200 pg/mL, respectively. The dearth of US subjects with clinically defined folate deficiency in the current era of folic acid-fortified cereal grain flour figured prominently in our decision regarding vitamin status cut points. 13, 14 PAR% estimates were calculated from the following formula: PAR%ϭ{[prevalence risk factor (RRϪ1)]/[prevalence risk factor (RRϪ1)ϩ1]}ϫ100. 19 Reported probability values were based on 2-tailed calculations, and all statistical analyses were performed by using SYSTAT (version 9.0) software.
Results
Key subject characteristics, expressed as means, geometric means, percentages, and complete ranges, are depicted in Table 1 . Geometric mean fasting tHcy levels were greater in the men (nϭ196) than in the women (nϭ71) at 8.5 versus 7.7 mol/L, respectively (Pϭ0.007). The prevalence of Ն12 mol/L plasma tHcy was 11.2% (30 of the 267 patients).
Logistic regression modeling was performed with Ն12 mol/L tHcy as the dependent variable and age, sex, PLP (continuous), albumin (continuous), Ͻ5 ng/mL folate, Ͻ250 pg/mL vitamin B 12 , and Ն1.3 mg/dL creatinine as the potential explanatory variables. Table 2 indicates the prevalence (percentage) of Ն1.3 mg/dL creatinine , Ͻ250 pg/mL vitamin B 12 , and Ͻ5 ng/mL folate, as well as the multivariable-adjusted relative risk estimates and PAR% for a Ն12 mol/L fasting tHcy conferred by these 3 potential explanatory variables. Stepwise forward selection and backward elimination revealed that Ն1.3 mg/dL serum creatinine (Pϭ0.002) and Ͻ250 pg/mL plasma vitamin B 12 (Pϭ0.008), but not Ͻ5 ng/mL plasma folate (Pϭ0.351), were independently predictive of a Ն12 mol/L fasting tHcy. PAR estimates (percentage) for a Ն12 mol/L tHcy, were as follows: Ͻ5 ng/mL folate (Ͻ1%), Ͻ250 pg/mL vitamin B 12 (24.5%), and Ն1.3 mg/dL creatinine (37.5%).
Discussion
All patients were examined at least several months after the widespread availability in southeast New England of cereal grain flour products (ie, all enriched wheat, corn, and rice flour products) fortified with folic acid at 140 g/100 g of flour. 18 Within a population-based sample of New England residents (ie, the Framingham Offspring cohort) who were nonusers of vitamin supplements, this fortification policy has doubled the plasma folate levels while reducing the prevalence of low folate levels (ie, Ͻ3 ng/mL) by Ͼ90% and the prevalence of Ͼ13 mol/L fasting tHcy levels by nearly 50%. 13 The very low point prevalence of Ͻ3 ng/mL plasma folate (ie, 4 [1.5%] of 267 patients) among the CAD patients examined in the present study is completely consistent with the prevalence of Ͻ3 ng/mL folate (1.0%, 95% CI 0.0% to 4.8%) among nonusers of supplements in the Framingham Offspring Study, who were similarly examined after the advent of fortification. 13 Moreover, these results with respect to the current dearth of plasma folate deficiency in US populations are consistent with findings from Canadian general populations 22 and CAD populations 23 examined after the initiation of the same flour fortification policy in Canada. Improved, relatively "homogeneous" folate status secondary to cereal grain fortification may have contributed to the lack of association between plasma folate and fasting tHcy levels observed in the present study. In contrast, the median age of the CAD patient population (61 years) could have accentuated the impact of age-related decrements in renal function 8 and vitamin B 12 status 24 on fasting plasma tHcy levels.
Persistent mild hyperhomocysteinemia is characteristic of patients with chronic renal insufficiency and end-stage renal disease. 25 The etiology of this hyperhomocysteinemia remains unknown, although it has been hypothesized to result from the loss of intrarenal homocysteine metabolism 26 and/or uremiainduced extrarenal defects in homocysteine metabolism. 27 In conjunction with earlier reports, 5-7 the present findings from clearly nonuremic subjects with, at most, only mild to moderate chronic renal insufficiency 28 might suggest that intrarenal homocysteine metabolism is a major determinant of homocysteine levels. However, these data cannot rule out the possibility that subtle extrarenal defects in homocysteine metabolism that may accompany even such mild reductions in renal function could account for the resulting increases in tHcy levels.
In summary, ever since the advent of folic acid fortification of cereal grain flour, renal insufficiency and suboptimal vitamin B 12 status, but not folate status, contribute importantly to the PAR for mild hyperhomocysteinemia among patients with stable CAD.
